Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway

Xing-Yong Chen; Shao-Fen Wan; Nan-Nan Yao; Ze-Jing Lin; Yan-Guang Mao; Xiao-Hua Yu; Yin-Zhou Wang

doi:10.1186/s40779-021-00356-x

Your Location：

Home >

Browse articles >

Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway

RESEARCH | Updated：2023-02-28

- Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
- Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
- 解放军医学杂志（英文版） 2022年9卷第4期页码：404-418
- Affiliations：
  
  1.Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134, Dongjie, Gulou District, Fuzhou 350001, China
  2.Fujian Academy of Medical Science, Fuzhou 350001, China
  3.Key Testing Laboratory of Fujian Province, Fuzhou 350001, China
- Author bio：
  
  * cxyong77@163.com;
  wphd@163.com
- Funds：
  
  the National Natural Science Foundation of China(81771250);the Natural Science Foundation of Fujian Province, China(2020J011059;2020R1011004);the Joint Funds for the Innovation of Science and Technology of Fujian Province, China(2017Y9065);the High-level hospital foster grants from Fujian Provincial Hospital, Fujian Province, China(2020HSJJ07)
- DOI：10.1186/s40779-021-00356-x
  中图分类号：
- 纸质出版：2022-08
- Accepted：
Scan QR Code
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway[J]. 解放军医学杂志（英文版）, 2022,9(4):404-418.

Chen XY, Wan SF, Yao NN, Lin ZJ, Mao YG, Yu XH, et al. Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway. Mil Med Res. 2021;8(1):62.
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway[J]. 解放军医学杂志（英文版）, 2022,9(4):404-418. DOI： 10.1186/s40779-021-00356-x.

Chen XY, Wan SF, Yao NN, Lin ZJ, Mao YG, Yu XH, et al. Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway. Mil Med Res. 2021;8(1):62. DOI： 10.1186/s40779-021-00356-x.

摘要

Abstract

Background:

Disruption of the blood–brain barrier (BBB) after a stroke can lead to brain injury and neurological impairment. Previous work confirmed the involvement of the immunoproteasome subunit of low molecular mass peptide 2 (LMP2) in the pathophysiology of ischemia stroke. However

the relationship between the immunoproteasome LMP2 and the BBB remains unclear.

Methods:

Adult male Sprague–Dawley rats were subjected to transient middle cerebral artery occlusion/reperfusion (MCAO/R). Three days before MCAO

the rats were treated with lentivirus-mediated LMP2 shRNA preparations by stereotactical injection into the ipsilateral hemispheric region. The rat brain microvascular endothelial cell (RBMVEC) line was exposed to oxygen–glucose deprivation/reperfusion (OGD/R) to mimic ischemic conditions

in vitro

. The RNA interference-mediated knockdown of LMP2 or

-catenin was analysed

in vivo

and

in vitro

. Analysis of the quantity of extravasated Evans blue (EB) and cerebral fluorescent angiography were performed to evaluate the integrity of the BBB. Immunofluorescence and Western blotting were employed to detect the expression of target proteins. Cell migration was evaluated using a scratch migration assay. The results of immunofluorescence

Western blotting and cell migration were quantified using the software ImageJ (Version 1.53). Parametric data from different groups were compared using one-way ANOVA followed by the least significant difference (LSD) test.

Results:

Cerebral ischemia led to lower levels of structural components of the BBB such as tight junction proteins [occludin

claudin-1 and zonula occludens (ZO-1)] in the MCAO/R group compared with the sham group (

0.001). However

inhibition of the immunoproteasome LMP2 restored the expression of these proteins

resulting in higher levels of occludin

claudin-1 and ZO-1 in the LMP2-shRNA group compared with the control-shRNA group (

0.001). In addition

inhibition of the immunoproteasome LMP2 contributed to higher microvascular density and decreased BBB permeability [e.g.

the quantity of extravasated EB: LMP2-shRNA group (58.54±7.37) μg/g

. control-shRNA group (103.74±4.32) μg/g

0.001]

and promoted the upregulation of Wnt-3a and β-catenin proteins in rats following MCAO/R.

In vitro

experiments

OGD/R induced marked upregulation of LMP2

proapoptotic protein Bax and cleaved caspase-3

and downregulation of occludin

claudin-1

ZO-1 and Bcl-2

as well as inhibition of the Wnt/β-catenin pathway Wnt-3a and β-catenin proteins in RBMVECs

compared with the control group under normal culture conditions (

0.001). However

silencing of LMP2 gene expression reversed these protein changes and promoted proliferation and migration of RBMVECs following OGD/R. Silencing of β-catenin by transfection of RBMVECs with β-catenin-siRNA aggravated the downregulation of tight junction proteins

and reduced the proliferation and migration of RBMVECs following OGD/R

compared with the control-siRNA group (

0.001). LMP2-siRNA and β-catenin-siRNA co-transfection partly counteracted the beneficial effects of silencing LMP2-siRNA on the levels of tight junction proteins in RBMVECs exposed to OGD/R.

Conclusions:

This study suggests that inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia induced BBB injury

and that the molecular mechanism involves the immunoproteasome-regulated activation of the Wnt/

-catenin signalling pathway under ischemic conditions.

关键词

Keywords

references

Jiang X , Andjelkovic AV , Zhu L , Yang T , Bennett M , Chen J , et al . Blood–brain barrier dysfunction and recovery after ischemic stroke . Prog Neurobiol . 2018 ; 163–164 : 144 - 71 . https://doi.org/10.1016/j.pneurobio.2017.10.001 https://doi.org/10.1016/j.pneurobio.2017.10.001 .

Sifat AE , Vaidya B , Abbruscato TJ . Blood–brain barrier protection as a therapeutic strategy for acute ischemic stroke . Aaps J . 2017 ; 19 ( 4 ): 957 - 72 . https://doi.org/10.1208/s12248-017-0091-7 https://doi.org/10.1208/s12248-017-0091-7 .

Abdullahi W , Tripathi D , Ronaldson PT . Blood–brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection . Am J Physiol Cell Physiol . 2018 ; 315 ( 3 ): C343 - 56 . https://doi.org/10.1152/ajpcell.00095.2018 https://doi.org/10.1152/ajpcell.00095.2018 .

Nian K , Harding IC , Herman IM , Ebong EE . Blood–brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction . Front Physiol . 2020 ; 11 : 605398 . https:// doi.org/10.3389/fphys.2020.605398 https:// doi.org/10.3389/fphys.2020.605398 .

Amani H , Habibey R , Hajmiresmail SJ , Latifi S , Pazoki-Toroudi H , Akhavan O . Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries . J Mater Chem B . 2017 ; 5 ( 48 ): 9452 - 76 . https://doi.org/10.1039/c7tb01689a https://doi.org/10.1039/c7tb01689a .

Doeppner TR , Mlynarczuk-Bialy I , Kuckelkorn U , Kaltwasser B , Herz J , Hasan MR , et al . The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF 1a accumulation and enhanced angioneurogenesis . Brain . 2012 ; 135 ( Pt 11 ): 3282 - 97 . https://doi.org/10.1093/brain/aws269 https://doi.org/10.1093/brain/aws269 .

Zhang L , Zhang ZG , Buller B , Jiang J , Jiang Y , Zhao D , et al . Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia . Stroke . 2010 ; 41 ( 5 ): 1001 - 7 . https://doi.org/10.1161/STROKEAHA.109.577288 https://doi.org/10.1161/STROKEAHA.109.577288 .

Doeppner TR , Kaltwasser B , Kuckelkorn U , Henkelein P , Bretschneider E , Kilic E , et al . Systemic proteasome inhibition induces sustained poststroke neurological recovery and neuroprotection via mechanisms involving reversal of peripheral immunosuppression and preservation of blood-brain-barrier integrity . Mol Neurobiol . 2016 ; 53 ( 9 ): 6332 - 41 . https://doi.org/10.1007/s12035-015-9533-3 https://doi.org/10.1007/s12035-015-9533-3 .

Chen X , Zhang X , Wang Y , Lei H , Su H , Zeng J , et al . Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke . Cell Death Dis . 2015 ; 6 ( 1 ): e1626 . https://doi.org/10.1038/cddis.2014.586 https://doi.org/10.1038/cddis.2014.586 .

Chen X , Zhang X , Chen T , Jiang X , Wang X , Lei H , et al . Inhibition of immunoproteasome promotes angiogenesis via enhancing hypoxia-inducible factor-1alpha abundance in rats following focal cerebral ischaemia . Brain Behav Immun . 2018 ; 73 : 167 - 79 . https://doi.org/10.1016/j.bbi.2018.04.009 https://doi.org/10.1016/j.bbi.2018.04.009 .

Liao J , Xie Y , Lin Q , Yang X , An X , Xia Y , et al . Immunoproteasome subunit beta5i regulates diet-induced atherosclerosis through altering MerTK-mediated efferocytosis in Apoe knockout mice . J Pathol . 2019 ; 250 ( 3 ): 275 - 87 . https://doi.org/10.1002/path.5368 https://doi.org/10.1002/path.5368 .

Basler M , Mundt S , Bitzer A , Schmidt C , Groettrup M . The immunoproteasome: a novel drug target for autoimmune diseases . Clin Exp Rheumatol . 2015 ; 33 ( 492 ): S74 - 9 .

Chen X , Wang Y , Fu M , Lei H , Cheng Q , Zhang X . Plasma immunoproteasome predicts early hemorrhagic transformation in acute ischemic stroke patients . J Stroke Cerebrovasc Dis . 2017 ; 26 ( 1 ): 49 - 56 . https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.08.027 https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.08.027 .

Chen XY , Fu M , Wan SF , Zhang X , Wang YZ . Association between plasma immunoproteasome and 90-day prognosis after first-ever ischemic stroke . Neural Regen Res . 2021 ; 16 ( 4 ): 790 - 5 . https://doi.org/10.4103/1673-5374.295344 https://doi.org/10.4103/1673-5374.295344 .

Yang C , Hawkins KE , Dore S , Candelario-Jalil E . Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke . Am J Physiol Cell Physiol . 2019 ; 316 ( 2 ): C135 - 53 . https://doi.org/10.1152/ajpcell.00136.2018 https://doi.org/10.1152/ajpcell.00136.2018 .

Yang W , Li L , Huang R , Pei Z , Liao S , Zeng J . Hypoxia inducible factor-1alpha mediates protection of DL-3-n-butylphthalide in brain microvascular endothelial cells against oxygen glucose deprivation-induced injury . Neural Regen Res . 2012 ; 7 ( 12 ): 948 - 54 . https://doi.org/10.3969/j.issn.1673-5374.2012.12.012 https://doi.org/10.3969/j.issn.1673-5374.2012.12.012 .

Bobadilla A , Arevalo J , Sarro E , Byrne HM , Maini PK , Carraro T , et al . In vitro cell migration quantification method for scratch assays . J R Soc Interface . 2019 ; 16 ( 151 ): 20180709 . https://doi.org/10.1098/rsif.2018.0709 https://doi.org/10.1098/rsif.2018.0709 .

Ferreira T , Rasband WS . ImageJ user guide-IJ 1.46r . 2012 . https://imagej.nih.gov/ij/docs/guide/index.html https://imagej.nih.gov/ij/docs/guide/index.html . Accessed 22 Feb 2021 .

Meller R . The role of the ubiquitin proteasome system in ischemia and ischemic tolerance . Neuroscientist . 2009 ; 15 ( 3 ): 243 - 60 . https://doi.org/10.1177/1073858408327809 https://doi.org/10.1177/1073858408327809 .

Doeppner TR , Kaltwasser B , Kuckelkorn U , Henkelein P , Bretschneider E , Kilic E , et al . Systemic proteasome inhibition induces sustained poststroke neurological recovery and neuroprotection via mechanisms involving reversal of peripheral immunosuppression and preservation of blood-brain–barrier integrity . Mol Neurobiol . 2016 ; 53 ( 9 ): 6332 - 41 . https://doi.org/10.1007/s12035-015-9533-3 https://doi.org/10.1007/s12035-015-9533-3 .

Ge P , Luo Y , Liu CL , Hu B . Protein aggregation and proteasome dysfunction after brain ischemia . Stroke . 2007 ; 38 ( 12 ): 3230 - 6 .

Angeles A , Fung G , Luo H . Immune and non-immune functions of the immunoproteasome . Front Biosci (Landmark Ed) . 2012 ; 17 ( 1 ): 1904 - 16 . https://doi.org/10.2741/4027 https://doi.org/10.2741/4027 .

Basler M , Lindstrom MM , LaStant JJ , Bradshaw JM , Owens TD , Schmidt C , et al . Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity . Embo Rep . 2018 ; 19 ( 12 ): e46512 . https://doi.org/10.15252/embr.201846512 https://doi.org/10.15252/embr.201846512 .

Basler M , Mundt S , Muchamuel T , Moll C , Jiang J , Groettrup M , et al . Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis . Embo Mol Med . 2014 ; 6 ( 2 ): 226 - 38 . https://doi.org/10.1002/emmm.201303543 https://doi.org/10.1002/emmm.201303543 .

Li J , Wang S , Zhang Y , Bai J , Lin Q , Liu R , et al . Immunoproteasome subunit β5i promotes Ang II (Angiotensin II)–induced atrial fibrillation by targeting ATRAP (Ang II type I receptor–associated protein) degradation in mice . Hypertension . 2019 ; 73 ( 1 ): 92 - 101 . https://doi.org/10.1161/HYPERTENSIONAHA.118.11813 https://doi.org/10.1161/HYPERTENSIONAHA.118.11813 .

Lu L , Wang H . Transient focal cerebral ischemia upregulates immunoproteasomal subunits . Cell Mol Neurobiol . 2012 ; 32 ( 6 ): 965 - 70 . https://doi.org/10.1007/s10571-012-9854-y https://doi.org/10.1007/s10571-012-9854-y .

Jean LeBlanc N , Menet R , Picard K , Parent G , Tremblay M , ElAli A . Canonical Wnt pathway maintains blood–brain barrier integrity upon ischemic stroke and its activation ameliorates tissue plasminogen activator therapy . Mol Neurobiol . 2019 ; 56 ( 9 ): 6521 - 38 . https://doi.org/10.1007/s12035-019-1539-9 https://doi.org/10.1007/s12035-019-1539-9 .

Lampugnani MG , Bravi L , Dejana E . The role of microvascular endothelial WNT signaling the formation of the blood brain barrier . Springerplus . 2015 ; 4 ( Suppl 1 ): L47 . https://doi.org/10.1186/2193-1801-4-S1-L47 https://doi.org/10.1186/2193-1801-4-S1-L47 .

Daneman R , Agalliu D , Zhou L , Kuhnert F , Kuo CJ , Barres BA . Wnt/betacatenin signaling is required for CNS, but not non-CNS, angiogenesis . Proc Natl Acad Sci USA . 2009 ; 106 ( 2 ): 641 - 6 . https://doi.org/10.1073/pnas.0805165106 https://doi.org/10.1073/pnas.0805165106 .

Liebner S , Corada M , Bangsow T , Babbage J , Taddei A , Czupalla CJ , et al . Wnt/beta-catenin signaling controls development of the blood–brain barrier . J Cell Biol . 2008 ; 183 ( 3 ): 409 - 17 . https://doi.org/10.1083/jcb.200806024 https://doi.org/10.1083/jcb.200806024 .

Tran KA , Zhang X , Predescu D , Huang X , Machado RF , Göthert JR , et al . Endothelial β-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis . Circulation . 2016 ; 133 ( 2 ): 177 - 86 . https://doi.org/10.1161/CIRCULATIONAHA.115.015982 https://doi.org/10.1161/CIRCULATIONAHA.115.015982 .

Lengfeld JE , Lutz SE , Smith JR , Diaconu C , Scott C , et al . Endothelial Wnt/beta-catenin signaling reduces immune cell infiltration in multiple sclerosis . Proc Natl Acad Sci USA . 2017 ; 114 ( 7 ): E1168 - 77 . https://doi.org/10.1073/pnas.1609905114 https://doi.org/10.1073/pnas.1609905114 .

Zhang J , Zhang J , Qi C , Yang P , Chen X , Liu Y . Activation of Wnt3α/β-catenin signal pathway attenuates apoptosis of the cerebral microvascular endothelial cells induced by oxygen–glucose deprivation . Biochem Biophys Res Commun . 2017 ; 490 ( 2 ): 71 - 7 . https://doi.org/10.1016/j.bbrc.2017.03.130 https://doi.org/10.1016/j.bbrc.2017.03.130 .

Salehi A , Jullienne A , Baghchechi M , Hamer M , Walsworth M , Donovan V , et al . Up-regulation of Wnt/beta-catenin expression is accompanied with vascular repair after traumatic brain injury . J Cereb Blood Flow Metab . 2018 ; 38 ( 2 ): 274 - 89 . https://doi.org/10.1177/0271678X17744124 https://doi.org/10.1177/0271678X17744124 .

Ma B , Hottiger MO . Crosstalk between Wnt/β-Catenin and NF-κB signaling pathway during inflammation . Front Immunol . 2016 ; 7 : 378 . https://doi.org/10.3389/fimmu.2016.00378 https://doi.org/10.3389/fimmu.2016.00378 .

Jin J , Wang W , Li A , Wu J . LMP7 inhibits the activation of NLRP3 inflammasome through interaction with NLRP3 . Biochem Biophys Res Commun . 2020 ; 2 ( 531 ): 152 - 9 . https://doi.org/10.1016/j.bbrc.2020.07.091 https://doi.org/10.1016/j.bbrc.2020.07.091 .

Li FD , Nie H , Tian C , Wang HX , Sun BH , Ren HL , et al . Ablation and inhibition of the immunoproteasome catalytic subunit LMP7 attenuate experimental abdominal aortic aneurysm formation in mice . J Immunol . 2019 ; 202 ( 4 ): 1176 - 85 . https://doi.org/10.4049/jimmunol.1800197 https://doi.org/10.4049/jimmunol.1800197 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Immune cells: potential carriers or agents for drug delivery to the central nervous system

840D车轮辐板孔裂纹扩展速率的统计分析

摆式列车线路检测信号的动态自适应滤波研究

基于ANSYS的EP电磁阀静态性能仿真分析

基于图像识别的轮轨冲角测量系统研究